Golden State Equity Partners Eli Lilly & CO Transaction History
Golden State Equity Partners
- $402 Million
- Q4 2023
A detailed history of Golden State Equity Partners transactions in Eli Lilly & CO stock. As of the latest transaction made, Golden State Equity Partners holds 2,481 shares of LLY stock, worth $2.15 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
2,481
Previous 2,210
12.26%
Holding current value
$2.15 Million
Previous $1.19 Million
21.82%
% of portfolio
0.36%
Previous 0.34%
Shares
11 transactions
Others Institutions Holding LLY
# of Institutions
3,747Shares Held
737MCall Options Held
7.09MPut Options Held
7.22M-
Lilly Endowment Inc Indianapolis, IN97.4MShares$84.3 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA72.7MShares$63 Billion1.14% of portfolio
-
Black Rock Inc. New York, NY65.3MShares$56.5 Billion1.2% of portfolio
-
Pnc Financial Services Group, Inc. Pittsburgh, PA51.4MShares$44.5 Billion27.92% of portfolio
-
State Street Corp Boston, MA34.3MShares$29.7 Billion1.21% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $823B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...